WESTMINSTER, CA-- (Aug 25, 2016) - BioLargo, Inc.
(OTCQB: BLGO) announced that it had entered into a new multi-year office lease of
approximately 8,800 square feet of office and warehouse space. The new facility opens official as BioLargo’s
office on September 1, 2016 and is located at 14921
Chestnut St., Westminster, CA 92683.
Joe
Provenzano, Vice President of Operations of BioLargo and President of Odor No
More, commented, "We are excited to secure a location that will allow us
to expand our manufacturing capabilities and operational support needs in order
to keep up with customer demand for our products, as well as to meet our basic
needs for corporate operations.”
AJ
Sexton, Vice President of Industrial Sales for Odor No More, added, “Current
customers of our CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com) continue to order, and we’re acquiring new customers and
starting new customer trials each month.”
Dennis
P. Calvert, President and CEO of BioLargo added, “Our new industrial facility
builds on the excitement from our technical symposium last week in Alberta Canada,
where we introduced our ‘alpha prototype’ AOS Filter System, the lowest cost and
highest impact clean water treatment system, now ready for commercial pilot
testing and implementation. Our decision to expand US operational support for our
odor control products is a response from the market and increasing sales.”
About BioLargo, Inc.
BioLargo,
Inc. (BLGO) makes
life better by delivering sustainable technology-based products that help solve
some of the most widespread problems threatening the world's supply of water,
food, agriculture, healthcare and energy. More information can be found about
the company and its subsidiaries at www.BioLargo.com. Its
subsidiary BioLargo Water, Inc. (www.BioLargoWater.com)
showcases the Advanced Oxidation Systems, including its AOS Filter -- a product
in development specifically designed to eliminate common, troublesome, and
dangerous (toxic) contaminants in water in a fraction of the time and cost of
current technologies. It is the winner of the Technology Star award by
New Technology Magazine for its breakthrough innovation for the oil industry
and is named the Technology Innovation Leader in the water treatment market by
Frost & Sullivan. BioLargo also owns a 50% interest in the Isan System,
which was honored with a "Top 50 Water Company for the 21st Century"
award by the Artemis Project now being commercialized under a license to Clarion
Water, Inc. BioLargo's subsidiary Odor-No-More Inc., features award-winning
products serving the pet, equine, military supply and consumer markets,
including the Nature's Best Solution® and Deodorall® brands (www.OdorNoMore.com).
BioLargo's subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com)
focuses on advanced wound care management.
Safe Harbor Statement
The
statements contained herein, which are not historical, are forward-looking
statements that are subject to risks and uncertainties that could cause actual
results to differ materially from those expressed in the forward-looking
statements, including, but not limited to, the risks and uncertainties included
in BioLargo's current and future filings with the Securities and Exchange
Commission, including those set forth in BioLargo's Annual Report on Form 10-K.
Contact:
Company Contact
Dennis
Calvert
President
and CEO
BioLargo,
Inc.
949-643-9540
x2